Capricor Therapeutics, Inc. (CAPR)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 10:53AM EDT. Market open.
| Previous close | 6.25 |
| Open | 6.25 |
| Bid | 6.05 x 200 |
| Ask | 6.18 x 200 |
| Day's range | 6.06 - 6.25 |
| 52-week range | 2.68 - 8.22 |
| Volume | |
| Avg. volume | 367,470 |
| Market cap | 194.368M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Capricor Therapeutics (NASDAQ:CAPR) shareholder returns have been stellar, earning 113% in 5 years
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...
- GuruFocus.com
Capricor Therapeutics Inc (CAPR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Unveiling key financial outcomes and strategic milestones, Capricor Therapeutics sets a robust path for 2024.
- Zacks
Capricor Therapeutics (CAPR) Reports Q1 Loss, Misses Revenue Estimates
Capricor (CAPR) delivered earnings and revenue surprises of -181.82% and 50.93%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.